Background and Aims: Hepatitis B Virus (HBV) remains the most common risk factor for hepatocellular carcinoma
(HCC). It has been suggested that, in addition to chronic inflammation, HBV viral
products directly contribute in HBV-driven hepatocellular carcinogenesis. In patients
with low HBV replication, it is proposed that accumulation of HBV surface antigen
(HBsAg) in the endoplasmic reticulum (ER) of hepatocytes (referred to as “ground glass
hepatocytes”) activates ER stress, directly driving carcinogenesis. In the ER stress
response, NF-kB is known to be important for the control of the Unfolded Protein Response
(UPR). The role of NF-kB signaling in HCC development has been reported to be on the
one hand anti-tumorigenic, due to activation of critical survival signals in hepatocytes.
On the other hand, NF-kB has also been identified as a tumor promoter due to its pro-inflammatory
function. In this study, we investigate the role of hepatic NF-kB signaling in directly
HBV-driven HCC development using mice overexpressing hepatitis B virus surface antigen
(HBsAg).
Methods: HBsAg transgenic mice were crossed with animals expressing a dominant-negative mutant
of IKK2 (an upstream kinase in canonical NF-kB signaling) under the control of tetracycline-inducible
LAP-promoter to achieve inhibition of hepatocellular canonical NF-kB signaling.
Results: The incidence of HBsAg-driven hepatocellular carcinogenesis was dramatically increased
at the age of 18 months, when canonical NF-kB signaling was inhibited. However, there
was no significant change in inflammatory response such as T-lymphocyte or macrophage
infiltration. In addition, MyD88 deficiency did not inhibit HBsAg-induced tumor development
in mice. Our data suggest that the role of canonical NF-kB signaling in this model
does not rely on changes in the inflammatory response, but disrupts UPR control in
HBsAg-driven hepatocellular carcinogenesis. Consistently, in HBsAg mice, a critical
UPR regulator BiP/GRP78 was not upregulated when canonical NF-kB system was blocked.
Furthermore, ER stress-associated cell death factor CHOP was strongly expressed, pointing
to a failure of UPR control. In addition, a massive oval cell reaction (ductular reaction)
was induced in HBsAg transgenic mice upon inhibition of canonical NF-kB signaling,
indicating extensive liver damage and lost capacity of hepatocytes to contribute to
compensatory proliferation.
Conclusion: The role of canonical NF-kB signaling in hepatocellular carcinogenesis depends on
the mode of liver damage. In the case of an HBsAg-driven HCC model simulating a direct
carcinogenic effect of HBV, NF-kB plays a critical role in controlling the ER stress
response. This implies an indispensable role for NF-kB in the control of the UPR and
an anti-tumorigenic role in ER stress-related hepatocarcinogenesis.
Corresponding author: Sunami, Yoshiaki
E-Mail:
yoshiaki.sunami@tum.de